ABBV | AbbVie Inc. Stock Overview

(Stock Exchange: NYSE)

Day's Range	165.65 - 167.91
52 Week Range	137.65 - 207.32
Beta	0.59
Implied Volatility	21.64%
IV Rank	31.41%
Day's Volume	3,019,167
Average Volume	5,397,465
Shares Outstanding	1,767,140,000
Market Cap	296,455,406,400
Sector	Healthcare
Industry	Drug Manufacturers - General
IPO Date	2013-01-02

Valuation
Profitability
Growth
Health
P/E Ratio	58.25
Forward P/E Ratio	15.36
EPS	2.88
1YR Price Target	175.00
Dividend Yield	3.94%
Dividend Per Share	4.28
Dividend ExDate	2024-01-12
Dividend PayDate	2024-02-15
Employees	50,000
Country	USA
Website	ABBV

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. The company's primary product is Humira, administered via injection.

ABBV's peers: MRK, PFE, LLY, BMY, JNJ, AMGN, GILD, ABT, AMRN, AZN, BIIB, GSK, NVS, OGN, SNY, SCLX

*Chart delayed

Analyzing fundamentals for ABBV we got that it has average fundamentals where Valuation is considered to be fairly valued, Profitability is moderate, Growth is good and Health is very weak. For more detailed analysis please see ABBV Fundamentals page.

Watching at ABBV technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ABBV Technicals page.